Skip to main content
Erschienen in: Cancer Causes & Control 1/2018

23.11.2017 | Original paper

Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings

verfasst von: Llucia Benito, Albert Farre, Gemma Binefa, Carmen Vidal, Angels Cardona, Margarita Pla, Montse García

Erschienen in: Cancer Causes & Control | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The effectiveness of screening in colorectal cancer prevention depends on sustained participation rates. The objective of this study was to explore factors related to the longitudinal adherence of screening behavior in the context of a biennial population-based cancer screening program.

Methods

Eight focus groups were conducted with individuals who were invited two or three consecutive times to a population-based colorectal cancer screening program using a fecal occult blood test and who agreed to participate in the program at least once (n = 45). The criteria used to select the study members included adherence to fecal occult blood test maintenance, factors regarding their initial participation in the colorectal cancer screening, sex, and contextual educational level.

Results

The participants expressed a high level of satisfaction with the program; however, they showed a low level of understanding with respect to cancer screening. Consulting a general practitioner was cited by all participants as an important factor that mediated their final decision or influenced their behavior as a whole with regard to the program. Fear played a different role in the screening behavior for regular and irregular adherent participants. In the adherent participants, fear facilitated their continued participation in the screening program, whereas for the irregular participants, fear led them to avoid or refuse further screening. Having a close person diagnosed with colorectal cancer was a facilitator for the regular adherent participants. The irregular adherent participants showed some relaxation with respect to screening after a negative result and considered that further screening was no longer necessary.

Conclusion

Considering the importance of primary healthcare professionals in the decision regarding sustained participation, it is important to better engage them with cancer screening programs, as well as improve the communication channels to provide accurate and balanced information for both health professionals and individuals.
Literatur
1.
Zurück zum Zitat Amonkar MM, Madhavan S, Rosenbluth SA, Simon KJ (1999) Barriers and facilitators to providing common preventive screening services in managed care settings. J Commun Health 24:229–247CrossRef Amonkar MM, Madhavan S, Rosenbluth SA, Simon KJ (1999) Barriers and facilitators to providing common preventive screening services in managed care settings. J Commun Health 24:229–247CrossRef
2.
Zurück zum Zitat Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J (2010) Once only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375:1624–1633CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J (2010) Once only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375:1624–1633CrossRefPubMed
3.
Zurück zum Zitat Beeker C, Kraft JM, Southwell BG, Jorgensen CM (2000) Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Commun Health 25:263–278CrossRef Beeker C, Kraft JM, Southwell BG, Jorgensen CM (2000) Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Commun Health 25:263–278CrossRef
4.
Zurück zum Zitat Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef
5.
Zurück zum Zitat Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Br Med J 348:g2467CrossRef Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Br Med J 348:g2467CrossRef
6.
Zurück zum Zitat Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M (2014) Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 146:709–717CrossRefPubMed Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M (2014) Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 146:709–717CrossRefPubMed
7.
Zurück zum Zitat Bridou M, Aguerre C, Gimenes G, Kubiszewski V, Le Gall A, Potard C, Sorel O, Reveillere C (2013) Psychological barriers and facilitators of colorectal cancer screening: a french qualitative study. Health Psychol Res 1:e22CrossRefPubMedPubMedCentral Bridou M, Aguerre C, Gimenes G, Kubiszewski V, Le Gall A, Potard C, Sorel O, Reveillere C (2013) Psychological barriers and facilitators of colorectal cancer screening: a french qualitative study. Health Psychol Res 1:e22CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Bulliard JL, De Landtsheer JP, Levi F (2004) Reattendance in the Swiss mammography screening pilot programme. J Med Screen 11:59Y64CrossRef Bulliard JL, De Landtsheer JP, Levi F (2004) Reattendance in the Swiss mammography screening pilot programme. J Med Screen 11:59Y64CrossRef
9.
Zurück zum Zitat Calazel-Benque A, Viguier J, Roussel C, Pivot X, Eisinger F, Blay JY, Coscas Y, Morère JF (2011) Organized colorectal cancer screening programmes: how to optimize efficiency in the general population. Eur J Cancer Prev 20:S20–S25CrossRefPubMed Calazel-Benque A, Viguier J, Roussel C, Pivot X, Eisinger F, Blay JY, Coscas Y, Morère JF (2011) Organized colorectal cancer screening programmes: how to optimize efficiency in the general population. Eur J Cancer Prev 20:S20–S25CrossRefPubMed
10.
Zurück zum Zitat Clemow L, Costanza ME, Haddad WP, Luckmann R, White MJ, Klaus D, Stoddard AM (2000) Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram. Ann Behav Med 22:80–88CrossRefPubMed Clemow L, Costanza ME, Haddad WP, Luckmann R, White MJ, Klaus D, Stoddard AM (2000) Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram. Ann Behav Med 22:80–88CrossRefPubMed
11.
Zurück zum Zitat Commission of the European Communities (CEC) (2003) Proposal for a council recommendation on cancer screening. 2003/0093 (CNS). Commission of the European Communities (CEC), Brussels Commission of the European Communities (CEC) (2003) Proposal for a council recommendation on cancer screening. 2003/0093 (CNS). Commission of the European Communities (CEC), Brussels
12.
Zurück zum Zitat Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C (2012) High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 10:633–638CrossRefPubMed Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C (2012) High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 10:633–638CrossRefPubMed
13.
Zurück zum Zitat Denis B, Gendre I, Perrin P (2015) Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. J Med Screen 22:76–82CrossRefPubMed Denis B, Gendre I, Perrin P (2015) Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. J Med Screen 22:76–82CrossRefPubMed
14.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Canc 49:1374–1403CrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Canc 49:1374–1403CrossRef
15.
Zurück zum Zitat García M, Borràs JM, Milà N, Espinàs JA, Binefa G, Fernández E, Farré A, Pla M, Cardona A, Moreno V (2011) Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study. Prev Med 52:265–267PubMed García M, Borràs JM, Milà N, Espinàs JA, Binefa G, Fernández E, Farré A, Pla M, Cardona A, Moreno V (2011) Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study. Prev Med 52:265–267PubMed
16.
Zurück zum Zitat Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, McDuffie JR, Østbye T, Yancy WS (2011) Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol 106:1125–1134CrossRefPubMed Gellad ZF, Stechuchak KM, Fisher DA, Olsen MK, McDuffie JR, Østbye T, Yancy WS (2011) Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol 106:1125–1134CrossRefPubMed
17.
Zurück zum Zitat Glaser BG (1965) The constant comparative method of qualitative analysis. Soc Probl 5(12):436–445CrossRef Glaser BG (1965) The constant comparative method of qualitative analysis. Soc Probl 5(12):436–445CrossRef
18.
Zurück zum Zitat Goel V, Gray R, Chart P, Fitch M, Saibil F, Zdanowicz Y (2004) Perspectives on colorectal cancer screening: a focus group study. Health Expect 7:51–60CrossRefPubMedPubMedCentral Goel V, Gray R, Chart P, Fitch M, Saibil F, Zdanowicz Y (2004) Perspectives on colorectal cancer screening: a focus group study. Health Expect 7:51–60CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T, Salvadori P, Visioli CB, Zappa M (2004) Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13:19–26CrossRefPubMed Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T, Salvadori P, Visioli CB, Zappa M (2004) Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13:19–26CrossRefPubMed
20.
Zurück zum Zitat Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477CrossRefPubMed
21.
Zurück zum Zitat Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103:1541–1549CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103:1541–1549CrossRefPubMed
22.
Zurück zum Zitat Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ (2010) Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59:62–68CrossRefPubMed Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ (2010) Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59:62–68CrossRefPubMed
23.
Zurück zum Zitat Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 25:907–917CrossRefPubMed Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 25:907–917CrossRefPubMed
24.
Zurück zum Zitat Jandorf L, Ellison J, Villagra C, Winkel G, Varela A, Quintero-Canetti Z, Castillo A, Thélémaque L, King S, Duhamel K (2010) Understanding the barriers and facilitators of colorectal cancer screening among low income immigrant Hispanics. J Immigr Minor Health 12:462–469CrossRefPubMedPubMedCentral Jandorf L, Ellison J, Villagra C, Winkel G, Varela A, Quintero-Canetti Z, Castillo A, Thélémaque L, King S, Duhamel K (2010) Understanding the barriers and facilitators of colorectal cancer screening among low income immigrant Hispanics. J Immigr Minor Health 12:462–469CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Jones RM, Devers KJ, Kuzel AJ, Woolf SH (2010) Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am Journal Prev Me 38:508–516CrossRef Jones RM, Devers KJ, Kuzel AJ, Woolf SH (2010) Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am Journal Prev Me 38:508–516CrossRef
26.
Zurück zum Zitat Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME (2014) Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 109:1257–1264CrossRefPubMed Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME (2014) Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 109:1257–1264CrossRefPubMed
27.
Zurück zum Zitat Khalid-de Bakker C, Jonkers D, Smits K, Mesters I, Masclee A, Stockbrügger R (2011) Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 43:1059–1086CrossRefPubMed Khalid-de Bakker C, Jonkers D, Smits K, Mesters I, Masclee A, Stockbrügger R (2011) Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 43:1059–1086CrossRefPubMed
28.
Zurück zum Zitat Krönborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467–1471CrossRefPubMed Krönborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467–1471CrossRefPubMed
29.
Zurück zum Zitat Leuraud K, Jezewski-Serra D, Viguier J, Salines E (2013) Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol 37:959–967CrossRefPubMed Leuraud K, Jezewski-Serra D, Viguier J, Salines E (2013) Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol 37:959–967CrossRefPubMed
31.
Zurück zum Zitat Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C (2014) Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 64:282–291CrossRefPubMedPubMedCentral Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C (2014) Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 64:282–291CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C (2015) Predictors of repeat participation in the NHS bowel cancer screening programme. BJC 112:199–206CrossRefPubMed Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C (2015) Predictors of repeat participation in the NHS bowel cancer screening programme. BJC 112:199–206CrossRefPubMed
33.
Zurück zum Zitat Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607CrossRefPubMed Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607CrossRefPubMed
34.
Zurück zum Zitat Marshall G (1994) A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 16:79Y86CrossRef Marshall G (1994) A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 16:79Y86CrossRef
35.
Zurück zum Zitat Maxwell A, Roshan B, Bradford C (1996) Predictors of interval mammography screening: results of a longitudinal study. J Womens Health 5:343Y349CrossRef Maxwell A, Roshan B, Bradford C (1996) Predictors of interval mammography screening: results of a longitudinal study. J Womens Health 5:343Y349CrossRef
37.
Zurück zum Zitat Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V (2012) Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000–2008. Gac Sanit 26:217–222CrossRefPubMed Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V (2012) Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000–2008. Gac Sanit 26:217–222CrossRefPubMed
38.
Zurück zum Zitat Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L (1993) Adherence to continuous screening for colorectal neoplasia. Med Care 31:508–519CrossRefPubMed Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L (1993) Adherence to continuous screening for colorectal neoplasia. Med Care 31:508–519CrossRefPubMed
40.
Zurück zum Zitat Nishihara R, Ogino S, Chan AT (2013) Colorectal-cancer incidence and mortality after screening. N Engl J Med 369:2355CrossRefPubMed Nishihara R, Ogino S, Chan AT (2013) Colorectal-cancer incidence and mortality after screening. N Engl J Med 369:2355CrossRefPubMed
41.
42.
Zurück zum Zitat Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M (1991) Factors affecting women’s response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 41:320Y322 Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M (1991) Factors affecting women’s response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 41:320Y322
43.
Zurück zum Zitat Palmer CK, Thomas MC, von Wagner C, Raine R (2014) Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer 110:1705–1711CrossRefPubMedPubMedCentral Palmer CK, Thomas MC, von Wagner C, Raine R (2014) Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer 110:1705–1711CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Panidi, Ksenia and Job Market. Ostrich effect in health care decisions: theory and empirical evidence. Diss. Dissertation (2014) Panidi, Ksenia and Job Market. Ostrich effect in health care decisions: theory and empirical evidence. Diss. Dissertation (2014)
45.
Zurück zum Zitat Papin-Lefebvre F, Guillaume E, Moutel G, Launoy G, Berchi C (2017) General practitioners’ preferences with regard to colorectal cancer screening organisation Colon cancer screening medico-legal aspects. Health Policy 121:1079–1084 Papin-Lefebvre F, Guillaume E, Moutel G, Launoy G, Berchi C (2017) General practitioners’ preferences with regard to colorectal cancer screening organisation Colon cancer screening medico-legal aspects. Health Policy 121:1079–1084
46.
Zurück zum Zitat Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P (2008) Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen 15:163–174CrossRefPubMed Parkin DM, Tappenden P, Olsen AH, Patnick J, Sasieni P (2008) Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen 15:163–174CrossRefPubMed
47.
Zurück zum Zitat Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. SAGE, London Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. SAGE, London
48.
Zurück zum Zitat Peipins LA, Shapiro JA, Bobo JK, Berkowitz Z (2006) Impact of women’s experiences during mammography on adherence to rescreening (United States). Cancer Causes Control 17:439Y447CrossRef Peipins LA, Shapiro JA, Bobo JK, Berkowitz Z (2006) Impact of women’s experiences during mammography on adherence to rescreening (United States). Cancer Causes Control 17:439Y447CrossRef
49.
Zurück zum Zitat Peris M, Espinas JA, Muñoz L, Navarro M, Binefa G, Borras JM (2007) Lessons learnt from a population-based pilot program for colorectal cancer screening in Catalonia (Spain). J Med Screen 14:81–86CrossRefPubMed Peris M, Espinas JA, Muñoz L, Navarro M, Binefa G, Borras JM (2007) Lessons learnt from a population-based pilot program for colorectal cancer screening in Catalonia (Spain). J Med Screen 14:81–86CrossRefPubMed
50.
Zurück zum Zitat Ponti A, Anttila A, Ronco G, Senore C (2017) Cancer Screening in the European Union Report on the implementation of the Council Recommendation on cancer screening. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening (reprint May 2017) Ponti A, Anttila A, Ronco G, Senore C (2017) Cancer Screening in the European Union Report on the implementation of the Council Recommendation on cancer screening. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening (reprint May 2017)
51.
Zurück zum Zitat Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O’Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, PLCO Project Team (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345–2357CrossRefPubMedPubMedCentral Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O’Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, PLCO Project Team (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345–2357CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C, SCORE Working Group (2011) Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst. 103:1310–1322CrossRefPubMed Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C, SCORE Working Group (2011) Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst. 103:1310–1322CrossRefPubMed
53.
Zurück zum Zitat Steele RJ, McClements PL, Libby G, Carey FA, Fraser CG (2014) Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis 16:28–32CrossRefPubMed Steele RJ, McClements PL, Libby G, Carey FA, Fraser CG (2014) Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis 16:28–32CrossRefPubMed
54.
Zurück zum Zitat Tinmouth J, Lansdorp-Vogelaar I, Allison JE (2015) Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64:1327–1337CrossRefPubMed Tinmouth J, Lansdorp-Vogelaar I, Allison JE (2015) Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64:1327–1337CrossRefPubMed
55.
Zurück zum Zitat van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135:82–90CrossRefPubMed van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135:82–90CrossRefPubMed
56.
Zurück zum Zitat van der Vlugt M, Grobbee EJ, Bossuyt PM, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Essink-Bot ML, Spaander MC, Dekker E (2017) Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer 116:44–49CrossRefPubMed van der Vlugt M, Grobbee EJ, Bossuyt PM, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Essink-Bot ML, Spaander MC, Dekker E (2017) Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer 116:44–49CrossRefPubMed
57.
Zurück zum Zitat von Euler-Chelpin M, Brasso K, Lynge E (2010) Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health 32:395–405CrossRef von Euler-Chelpin M, Brasso K, Lynge E (2010) Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health 32:395–405CrossRef
58.
Zurück zum Zitat von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P (2008) Cancer screening in the European Union. Report on the implementation of the Council Recommendation on Cancer Screening. International Agency for Research of Cancer, European Communities von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, Segnan N, Castillo-Beltran M, Boniol M, Ferlay J, Hery C, Sauvaget C, Voti L, Autier P (2008) Cancer screening in the European Union. Report on the implementation of the Council Recommendation on Cancer Screening. International Agency for Research of Cancer, European Communities
59.
Zurück zum Zitat von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 40:712–718 von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 40:712–718
60.
Zurück zum Zitat Vrinten C, Waller J, von Wagner C, Wardle J (2015) Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 24:400–405CrossRefPubMedPubMedCentral Vrinten C, Waller J, von Wagner C, Wardle J (2015) Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 24:400–405CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Weller DP, Patnick J, McIntosh HM, Dietrich AJ (2009) Uptake in cancer screening programmes. Lancet Oncol 10:693–699CrossRefPubMed Weller DP, Patnick J, McIntosh HM, Dietrich AJ (2009) Uptake in cancer screening programmes. Lancet Oncol 10:693–699CrossRefPubMed
62.
Zurück zum Zitat Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG (1993) Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 85:1311–1318CrossRefPubMed Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG (1993) Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 85:1311–1318CrossRefPubMed
63.
Zurück zum Zitat Wong RK, Wong ML, Chan YH, Feng Z, Wai CT, Yeoh KG (2013) Gender differences in predictors of colorectal cancer screening uptake: a national cross-sectional study based on the health belief model. BMC Public Health 13:677–688CrossRefPubMedPubMedCentral Wong RK, Wong ML, Chan YH, Feng Z, Wai CT, Yeoh KG (2013) Gender differences in predictors of colorectal cancer screening uptake: a national cross-sectional study based on the health belief model. BMC Public Health 13:677–688CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Wools A, Dapper EA, de Leeuw JR (2016) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26:158–168CrossRefPubMed Wools A, Dapper EA, de Leeuw JR (2016) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26:158–168CrossRefPubMed
Metadaten
Titel
Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings
verfasst von
Llucia Benito
Albert Farre
Gemma Binefa
Carmen Vidal
Angels Cardona
Margarita Pla
Montse García
Publikationsdatum
23.11.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 1/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0982-z

Weitere Artikel der Ausgabe 1/2018

Cancer Causes & Control 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.